Evidence map›Paper›PMID 29167182›Full record

ArticleEndocrine-related cancer2018

Paula Fontes Asprino, Rudinei Diogo Marques Linck, Jônatas Cesar, Florêncio Porto Freitas, Fernanda Christtanini Koyama, Rachel Simões Pimenta Riechelmann, Frederico Perego Costa, Paulo Marcelo Gehm Hoff, Pedro Alexandre Favoretto Galante, Diogo Meyer and 2 more

Abstract readLetter
In one paragraph

Article in Endocrine-related cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Paula Fontes AsprinoHospital Sírio-Libanês (HSL)São Paulo, São Paulo, Brazil.
Rudinei Diogo Marques LinckHospital Sírio-Libanês (HSL)São Paulo, São Paulo, Brazil.
Jônatas CesarInstituto de Biociências - Universidade de São Paulo (IB-USP)São Paulo, São Paulo, Brazil.
Florêncio Porto FreitasHospital Sírio-Libanês (HSL)São Paulo, São Paulo, Brazil.
Fernanda Christtanini KoyamaHospital Sírio-Libanês (HSL)São Paulo, São Paulo, Brazil.
Rachel Simões Pimenta RiechelmannInstituto do Câncer do Estado de São Paulo (ICESP)São Paulo, São Paulo, Brazil.
Frederico Perego CostaHospital Sírio-Libanês (HSL)São Paulo, São Paulo, Brazil.
Paulo Marcelo Gehm HoffHospital Sírio-Libanês (HSL)São Paulo, São Paulo, Brazil.
Pedro Alexandre Favoretto GalanteHospital Sírio-Libanês (HSL)São Paulo, São Paulo, Brazil.
Diogo MeyerInstituto de Biociências - Universidade de São Paulo (IB-USP)São Paulo, São Paulo, Brazil.
Anamaria Aranha CamargoHospital Sírio-Libanês (HSL)São Paulo, São Paulo, Brazil.
Jorge SabbagaHospital Sírio-Libanês (HSL)São Paulo, São Paulo, Brazil jsabbaga@uol.com.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Germ-Line MutationHumansIntestinal NeoplasmsMiddle AgedMutation, MissenseNeuroendocrine TumorsPancreatic NeoplasmsSclerosisStomach NeoplasmsTuberous Sclerosis Complex 2 ProteinTSC2 protein, humanTuberous Sclerosis Complex 2 Protein

Identifiers

PMID29167182
PMCPMC5763421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.